CIK 0001559053 · Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 011-353-1-236-2500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | Nguyen Tran Chief Strategy Officer and CFO | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2026-03-03 | Malecek Michael J Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2026-03-03 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +520,000 | 520,000 | ||
| 2025-07-28 | Zago Wagner M. Chief Scientific Officer | Grant or award | +85,000 | 85,000 | ||
| 2025-07-28 | Walker Karin L Chief Accounting Officer | Grant or award | +25,000 | 25,000 | ||
| 2025-07-28 | Swanson Chad J. Chief Development Officer | Grant or award | +85,000 | 85,000 | ||
| 2025-07-28 | Smith Brandon S. Chief Operating Officer | Grant or award | +130,000 | 130,000 | ||
| 2025-07-28 | Nguyen Tran Chief Strategy Officer and CFO | Grant or award | +95,000 | 97,205 | ||
| 2025-07-28 | Malecek Michael J Chief Legal Officer | Grant or award | +80,000 | 80,000 | ||
| 2025-07-28 | Kinney Gene G. President and CEO | Grant or award | +140,000 | 152,793 | ||
| 2025-05-14 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | Selkoe Dennis J. Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | Kim Helen Susan Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | Dunn William H. Jr. Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | Cooke Shane Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | COLLIER RICHARD T Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-14 | Cobb Paula K Director | Grant or award · Stock Option (Right to Buy) | +20,183 | 20,183 | ||
| 2025-05-06 | EcoR1 Capital, LLC 10% owner | Sale | −1,984,053 | $7.64 | $15.2M | 5,304,596 |
| 2025-05-05 | EcoR1 Capital, LLC 10% owner | Sale | −977,693 | $8.11 | $7.9M | 7,288,649 |
Page 4 of 9 · 172 trades